A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects
Clinical trial NCT07264335 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07264335
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-07
- Primary completion
- 2026-04-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.